Today: 10 June 2026
Browse Category

NYSE:SMAR 7 May 2026

DocuSign Adds Redis CEO to Board as AI Contract Push Faces Bigger Test

DocuSign Adds Redis CEO to Board as AI Contract Push Faces Bigger Test

Docusign appointed Redis CEO Rowan Trollope to its board, effective May 2, according to a regulatory filing Wednesday. Shares rose 4.1% to $48.43 after the announcement. Trollope, 53, fills a Class III director seat expiring in 2027. The move comes as Docusign expands into contract-management software beyond e-signatures.

Stock Market Today

  • Banco Santander Undervalued Despite Strong Three-Year Rally, Says Analysis
    June 10, 2026, 5:13 AM EDT. Banco Santander shares at €10.48 have surged over three years, returning more than 3x. Yet, valuation analysis using excess returns-a measure comparing a company's profitability with its cost of equity-indicates the stock is about 42.9% undervalued, suggesting potential upside. The bank's average return on equity stands at 15.57%, exceeding its 0.70 euro cost of equity per share, underpinning the undervaluation estimate. While short-term price movements show minor slips, Santander's sustained profitability and position among large European banks continue to attract investor interest. Financial metrics like price-to-earnings and discounted cash flow are also used to gauge its fair value. These insights encourage investors to reassess expectations amid changing global interest rates and regulatory influences on bank profitability.

Latest articles

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

10 June 2026
LVMH shares slipped 0.49% to €489.90 in Paris after a four-day rebound, as investors weighed RBC’s reiterated Buy rating with a €600 target against ongoing 2026 losses and a 24% year-to-date drop; all eyes now turn to July’s first-half results for signs of recovery in Fashion & Leather Goods and any relief from Middle East weakness.
Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

10 June 2026
Roche’s participation certificates climbed 1.07% to CHF 322.20 after announcing a $2.3 billion deal with Nurix Therapeutics for late-stage blood-cancer drug bexobrutideg, planned to enter Phase 3 trials this summer in CLL, as investors weigh the asset’s potential to offset losses from expiring patents and drive mid-single-digit sales growth in 2026.
YY Group Shares Jump Premarket on Humanoid Robot Move

YY Group Shares Jump Premarket on Humanoid Robot Move

10 June 2026
YYGH jumped to $0.19 in early pre-market after announcing deployment of Unitree G1 humanoid robots for facility management, aiming to turn operational know-how into higher-margin data assets, but the stock remains volatile near record lows after a recent reverse split and has not confirmed robot-driven revenue or margin gains.
Tencent Shares Gain After $4.66B Bond Sale Seen Fueling AI Bets

Tencent Shares Gain After $4.66B Bond Sale Seen Fueling AI Bets

10 June 2026
Tencent shares jumped 3.22% to HK$467.80 after the company priced a larger-than-expected US$4.66 billion dual-currency bond deal, drawing over US$17 billion in orders and allowing tighter pricing, as investors weighed Tencent’s ability to fund rising AI investments while maintaining strong cash flow and ongoing share buybacks.
PAVS Stock Jumps Again, $195M Share Sale Filing in Focus

PAVS Stock Jumps Again, $195M Share Sale Filing in Focus

10 June 2026
Paranovus Entertainment Technology shares jumped 19.6% premarket after filing plans for an at-the-market share sale of up to $194.99 million—an unusually large amount compared to its $1.07 million market value—raising dilution risks as the company can sell shares at prevailing prices with no minimums, while recent trading has been highly volatile and underlying operations remain limited.
Go toTop